NEC National Security Systems Shows Commitment to Ending Human Trafficking by Joining Forces With InfraGard National Members Alliance as 2023 Diamond Sponsor
NEC National Security Systems (NEC NSS), a leading provider of biometric identity and artificial intelligence (AI) technology for federal government agencies in defense, intelligence, law enforcement, and homeland security has recommitted to InfraGard National Members Alliance (INMA) as a 2023 Diamond Sponsor. The sponsorship, which began in January 2022, is dedicated to fighting human trafficking and protecting critical infrastructure and the American people.
KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya
The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya. Validation of this system is taking place through KEMRI with a clinical trial that began in September 2022 at the Kinango Sub-County Hospital in Kwale.
NEC Develops Autonomous Mobile Robot Control Technology That Doubles Efficiency While Maintaining Safety
NEC Corporation (NEC; TYO: 6701) today announced the development of a control technology that doubles the efficiency of autonomous mobile robots (AMR) in warehouses while maintaining a high level of safety. NEC plans to put this technology into practical use by March 2024 and to have it installed in NEC's cooperative AMRs in Japan.
NEC Holds No.1 Position for 7 Years in a Row as Worldwide Leader in SMB Business Phone Systems
NEC, a global leader in communications & IT solutions, today announced that for seven years in a row it has been recognized as the global no.1 in SMB (Small and Medium Business) Business Phone Systems. This success underscores once again the strength of NEC's portfolio, the company's commitment to expand its global enterprise footprint and the ability to serve customers to fullest satisfaction.
NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic
NEC Corporation (NEC; TOKYO: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new technology, called “Cx20,” while seeking to assist in the early detection of colorectal lesions. Cx20 has already met the requirements for CE marking, a European safety, health and environmental protection standard, and will be integrated in the medical device AI diagnostic support software "WISE VISION® Endoscopy" (*1), with sales expected to start in Europe later this year.
